Product Information
OXCARBAZEPINE ER 150 MG TABLET is a generic product labeled by Ajanta Pharma USA Inc., priced at $3.3733 per EA under NDC 27241023701. Its NADAC has been published 55 times since Aug 6, 2025.
FDA first approved this application on Feb 22, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Oxcarbazepine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
150 mg/1
Manufacturer
Ajanta Pharma USA Inc.NDC
27241023701
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
OXCARBAZEPINEApproval Type
Generic (ANDA)
FDA Application
ANDA217659FDA Approved
2/22/2024
TE Code
AB
On Market Since
2/22/2024
Pharmacological Classes
Price Statistics
The NADAC for OXCARBAZEPINE ER 150 MG TABLET has been published 55 times since Aug 6, 2025, and over the history we have for it it has declined 49.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.3733 per EA |
|---|---|
| All-time high | $6.7143 (Aug 13, 2025) |
| All-time low | $3.3733 (Aug 19, 2026) |
| 52-week high | $6.6578 |
| 52-week low | $3.3733 |
| Median price | $4.9809 |
| Average price | $5.0055 |
| Largest weekly change | -14.7% (Jun 17, 2026) |
| Weeks tracked | 55 |
| Tracking since | Aug 6, 2025 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 97% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OXCARBAZEPINE ER 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXCARBAZEPINE ER 150 MG TABLET, manufactured by Ajanta Pharma USA Inc., is $3.3733 per EA (NDC 27241023701), effective Aug 19, 2026.
How has the price of OXCARBAZEPINE ER 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXCARBAZEPINE ER 150 MG TABLET has declined 49.8%. It has been tracked across 55 weekly CMS publications since Aug 6, 2025.
What are the highest and lowest recorded NADAC prices for OXCARBAZEPINE ER 150 MG TABLET?
Since Aug 6, 2025, the NADAC for OXCARBAZEPINE ER 150 MG TABLET has ranged from a low of $3.3733 (Aug 19, 2026) to a high of $6.7143 (Aug 13, 2025), with a median of $4.9809 per EA.
Are there cheaper alternatives to OXCARBAZEPINE ER 150 MG TABLET?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OXCARBAZEPINE 150 MG TABLET, is $0.1037 per EA — about 97% below OXCARBAZEPINE ER 150 MG TABLET.
Who manufactures OXCARBAZEPINE ER 150 MG TABLET?
OXCARBAZEPINE ER 150 MG TABLET (NDC 27241023701) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.